Synergy Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies, has appointed Gary Sender as executive vice president and chief financial officer. Mr. Sender will be responsible for leading Synergy’s financial strategy and operations, supporting all functions of the organization. “Gary is a strong leader whose broad experience in small and larger specialty pharmaceutical organizations uniquely qualifies him t...